MAUDE Adverse Event Report: PRINGY JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

Catalog Number	20073770
Medical Device Problem Codes	Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Obstruction/Occlusion (2422)
Date of Event	03/29/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
Event or Problem Description
Healthcare professional reported that a patient was injected with 4 syringes of juvéderm® volux¿ xc in the jawline and chin.Two days later the patient is experiencing a vascular occlusion.The physician treated the area with hylenex but the issues are ongoing.
Event or Problem Description
Additionally, healthcare professional stated that the patient was injected with 1 cc of juvéderm® volux¿ xc.Post injection the patient experienced pain, and a vascular occlusion at the site of injection.The patient would not shave beard because it was hard for them to see skin changes during or event post injection, pain was persistent.The hcp injected the patient 4 rounds of 1800 units of hylenex sometimes twice a day.Symptoms resolved.
Additional Manufacturer Narrative
Additional, corrected, and/or changed data: a4, a6, b5, h6, h8.
Event or Problem Description
Additionally, healthcare professional stated that the patient was injected with 1 cc of juvéderm® volux¿ xc.Post injection the patient experienced pain, and a vascular occlusion at the site of injection.The patient would not shave beard because it was hard for them to see skin changes during or event post injection, pain was persistent.The hcp injected the patient 4 rounds of 1800 units of hylenex sometimes twice a day.Symptoms resolved.
Additional Manufacturer Narrative
Additional, corrected, and/or changed data: h6.

• Brand Name: JUVEDERM VOLUX XC 2 X 1ML
• Common Device Name: IMPLANT, DERMAL, FOR AESTHETIC USE
• Manufacturer (Section D): PRINGY; route de promery; zone artisanale de pre-mairy; pringy 74370 ; FR 74370
• Manufacturer (Section G): PRINGY; route de promery; zone artisanale de pre-mairy; pringy 74370 ; FR 74370
• Manufacturer Contact: terry ingram ; 2525 dupont drive; irvine, CA 92612 ; 8479366324
• MDR Report Key: 21850913
• Report Number: 3005113652-2025-00345
• Device Sequence Number: 15605362
• Product Code: LMH
• UDI-Device Identifier: 10840228300073
• UDI-Public: (01)10840228300073(10)1000565587(11)230109(17)241209
• Combination Product (Y/N): Y
• Initial Reporter State: CA
• Initial Reporter Country: US
• PMA/510(K) Number: P110033
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Reporter Type: Manufacturer
• Report Source: Health Professional,Company Representative
• Initial Reporter Occupation: Nurse
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 04/29/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 12/09/2024
• Device Catalogue Number: 20073770
• Device Lot Number: 1000565587
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: 04/10/2025
• Supplement Date Received by Manufacturer: 04/15/2025; 04/25/2025
• Initial Report FDA Received Date: 04/16/2025
• Supplement Report FDA Received Date: 04/24/2025; 04/29/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 01/09/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 51 YR
• Patient Sex: Male
• Patient Weight: 75 KG
• Patient Race: White